Nephros NEPH
NASDAQ NEPH
$3.31 +0.24 (+7.82%)
At close: Nov 12, 2026 · 4:00 PM EST

Nephros (NEPH) Liabilities from Discontinued Operations (2021 - 2022)

Updated

Nephros (NEPH) posted Liabilities from Discontinued Operations of $72,000 for Q4 2021.

Analysis

Nephros (NEPH) Liabilities from Discontinued Operations (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.20 Bn 235.84 Bn 5.13 Bn
2 Abbott Laboratories 185.80 Bn 160.26 Bn 7.39 Bn
3 Danaher 163.29 Bn 142.96 Bn 3.84 Bn
4 Intuitive Surgical 152.47 Bn 132.89 Bn 2.08 Bn
5 Medtronic 131.95 Bn 97.47 Bn 6.34 Bn
6 Stryker 119.59 Bn 105.78 Bn 4.25 Bn
7 Boston Scientific 64.18 Bn 59.61 Bn 3.43 Bn
8 Edwards Lifesciences 60.93 Bn 44.24 Bn 1.35 Bn
9 Medline 52.61 Bn 49.74 Bn 1.93 Bn
10 Nephros 35.98 Mn 17.32 Mn 3.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 130,000.00
Dec 31, 2021 72,000.00
API Access

Nephros Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=NEPH&period=max&api_key=YOUR_API_KEY